Showing results 1 to 20 of 25
next >
Title | Author(s) | Issue Date | |
---|---|---|---|
Aptamer-based inhibitor of sclerostin for Osteoporosis Therapy Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | ||
Aptamer-mediated inhibition of Mycobacterium tuberculosis polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Biochemistry Postgraduate Symposium | 2010 | ||
Aptamer-mediated Inhibition of Mycobacterium tuberculosis Polyphosphate Kinase 2 Proceeding/Conference:Hong Kong Chemical Biology Symposium | 2009 | ||
Aptamers against polyphosphate kinase 2 (PPK2) from mycobacterium tuberculosis as a potential approach of novel anti-tuberculosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | ||
Dissecting the mechanism of binding between polyphosphate and polyphosphate kinase 2 Proceeding/Conference:Hong Kong Inter-University Postgraduate Symposium | 2012 | ||
Dissecting the mechanism of how mycobacterium tuberculosis polyphosphate kinase 2 binds to polyphosphate Proceeding/Conference:Annual Meeting of the European Molecular Biology Organisation, EMBO 2013 | 2013 | ||
DNA aptamers binding H5N1 virus nucleoprotein showed antiviral effects Proceeding/Conference:Keystone Symposia on Molecular and Cellular Biology 2011: Evolving Approaches to Early-Stage Drug Discovery | 2011 | ||
Effect of inorganic polyphosphate on higher eukaryotic cells Proceeding/Conference:Research Postgraduate Symposium, RPS 2009 | 2009 | ||
G-quadruplex aptamers inhibit sclerostin for osteoporosis therapy Proceeding/Conference:Croucher Foundation ASI Conference on Structure-Based Screening & Design of Ligands for Protein Targets | 2009 | ||
In vitro aptamer selection against the SARS Coronavirus Helicase Proceeding/Conference:Annual Symposium of the Hong Kong Proteomics Society, HKPS 2007 | 2007 | ||
In vitro aptamer selection against the SARS coronavirus helicase and their intracellular delivery Proceeding/Conference:Annual Meeting of the Oligonucleotide Therapeutic Society, OTS 2007 | 2007 | ||
In vitro selection of DNA aptamers binding H5N1 Virus nucleoprotein Proceeding/Conference:Research Postgraduate Symposium, RPS 2008 | 2008 | ||
Inhibiting sclerostin with a nucleic acid aptamer as a new approach to osteoporosis therapy Proceeding/Conference:Johnson & Johnson Asia Outstanding Graduate Thesis Award in Bio-tech | 2011 | ||
Inorganic polyphosphate triggers interleukin 11 production in osteoblasts cell signalling Proceeding/Conference:The FEBS Journal | 2013 | ||
Investigation of the protein/polyphosphate binding interface: mutational studies on mycobacterium tuberculosis polyphosphate kinase 2 (PPK2) Proceeding/Conference:Research Postgraduate Symposium, RPS 2012 | 2012 | ||
New approaches for therapeutic aptamer selection and delivery Proceeding/Conference:MGH-HKU-Nature China Forum | 2007 | ||
New approaches for therapeutic aptamer selection and delivery Proceeding/Conference:Annual Symposium of the Hong Kong Proteomics Society, HKPS 2007 | 2007 | ||
New approaches to osteoporosis therapy with aptamer-based inhibitors Proceeding/Conference:Annual Meeting of the Oligonucleotide Therapeutics Society, OTS 2010 | 2010 | ||
New selection and delivery approaches for nucleic acid aptamers against proteomic targets Proceeding/Conference:Annual World Congress of the Human Proteome Organization, HUPO 2007 | 2007 | ||
Polyphosphate regulates interleukin-11 levels of SaOS-2 cells Proceeding/Conference:Hong Kong Inter‐University Biochemistry Postgraduate Symposium | 2013 |